XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
Derivative Instruments and Hedging Activities
3 Months Ended
Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities
11.
Derivative Instruments and Hedging Activities
Interest Rate Risk Management
Concurrent with the Company’s July 13, 2017 borrowings under its credit facility, the Company entered into a 44–month interest-rate swap to convert the debt’s variable interest rate to a fixed rate of interest. The swap contracts, which matured on April 1, 2021, were designated as cash flow hedging instruments and qualified as effective hedges at inception under ASC Topic 815, “Derivatives and Hedging”. These contracts were recognized on the balance sheet at fair value. The effective portion of the changes in fair value on these instruments was recorded in other comprehensive income (loss) and was reclassified into the Consolidated Statements of Operations as interest expense in the same period in which the underlying hedge transaction affected earnings. Because the interest-rate swap contracts matured, they had no value as of March 31, 2022, and December 31, 2021, therefore there is no balance reflected in the Consolidated Balance Sheets for these periods.
There was no impact on the Consolidated Statements of Operations and Comprehensive Income (“OCI”) for the three months ended March 31, 2022. The effect of derivative instruments on the Consolidated Statements of Operations and OCI for the three months ended March 31, 2021 are as follows (in thousands):

                     
Derivatives in
ASC Topic 815
Cash Flow
Hedging
Relationships
  
Amount of
Gain
recognized in OCI
on Derivatives
  
Location of
Gain
reclassified from
Accumulated OCI
to Income
  
Amount of
Gain
reclassified from
Accumulated OCI
to Income
  
Location of
Gain
reclassified in
Income on
Derivatives
  
Amount of
Gain
recognized
in
Income on
Derivatives
                          
     (Effective Portion)    (Effective Portion)    (Effective Portion)   
(Ineffective Portion/Amounts excluded
from effectiveness testing)
Interest-Rate Swap Contracts
   $35    Interest Expense    $34    Interest Expense    $—